R.E.E.L. OUTLINE
LIVE

Serial Number

87101312

Owner

R.E.E.L. OUTLINE INC.

Attorney

Marcella Ballard

Filing Date

Jul 12, 2016

Add to watchlist:

No watchlists yet
View on USPTO

R.E.E.L. OUTLINE Trademark

Serial Number: 87101312 • Registration: 6810991

R.E.E.L. OUTLINE is a trademark filed by R.E.E.L. OUTLINE INC. on July 12, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

R.E.E.L. OUTLINE INC.

Windsor, Ontario N9G2X5 , CA

Entity Type: 03

Trademark Details

Filing Date

July 12, 2016

Registration Date

August 9, 2022

Published for Opposition

May 24, 2022

Goods & Services

Computer programs, namely, educational software for use on desktops, portable computers, tablet computers, portable digital assistants and smart phones, to be used by pharmacists, physicians, nurses, dietitians, nurse practitioners, students and other healthcare professionals to educate patients about chronic disease management and drug therapy; Computer software, namely, downloadable web-based software programs for storing and managing electronic healthcare data, managing medication reviews, chronic disease management, creating drug-related interventions to ensure patients are on the best regimens according to various guidelines recognized in the healthcare industry which may or may not require physician approval, creating follow up appointments with patients to review chronic disease management, collection of statistics in the field of chronic disease management and drug therapy for use by doctors, pharmacists, physicians, nurses, dietitians, nurse practitioners and other healthcare professionals to be used along with patients

Software as a service (SAAS), namely, providing temporary use of non-downloadable web-based computer programs for storing and managing electronic healthcare data, managing medication reviews, chronic disease management, creating drug-related interventions to ensure patients are on the best regimens according to various guidelines recognized in the healthcare industry which may or may not require physician approval, creating follow up appointments with patients to review chronic disease management, collection of statistics in the field of chronic disease management and drug therapy for use by doctors, pharmacists, physicians, nurses, dietitians, nurse practitioners and other healthcare professionals to be used along with patients

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 9, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 9, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 21, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2021 CRFA
ASSIGNED TO LIE
Jul 1, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 5, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 17, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 17, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 17, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 18, 2020 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 24, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 24, 2020 GNSL
SUSPENSION LETTER WRITTEN
Feb 24, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 12, 2019 ERSI
ASSIGNED TO EXAMINER
Oct 30, 2019 DOCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 21, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 21, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 21, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 19, 2019 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 19, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 19, 2018 GNSL
SUSPENSION LETTER WRITTEN
Dec 19, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 18, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 27, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 27, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 27, 2018 CNSI
SUSPENSION INQUIRY WRITTEN
Jun 27, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 4, 2018 RCCK
ASSIGNED TO LIE
May 31, 2018 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 15, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 15, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
May 15, 2017 GNSL
SUSPENSION LETTER WRITTEN
May 15, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2017 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 25, 2017 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 3, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 3, 2017 GNSL
SUSPENSION LETTER WRITTEN
Mar 3, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2017 CRFA
ASSIGNED TO LIE
Feb 20, 2017 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 9, 2017 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 20, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jul 19, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2016 NWOS
NEW APPLICATION ENTERED
Jul 15, 2016 NWAP